BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

821 related articles for article (PubMed ID: 31530567)

  • 1. N
    Li F; Yi Y; Miao Y; Long W; Long T; Chen S; Cheng W; Zou C; Zheng Y; Wu X; Ding J; Zhu K; Chen D; Xu Q; Wang J; Liu Q; Zhi F; Ren J; Cao Q; Zhao W
    Cancer Res; 2019 Nov; 79(22):5785-5798. PubMed ID: 31530567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential role of METTL3-mediated m
    Visvanathan A; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Oncogene; 2018 Jan; 37(4):522-533. PubMed ID: 28991227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m
    Cui Q; Shi H; Ye P; Li L; Qu Q; Sun G; Sun G; Lu Z; Huang Y; Yang CG; Riggs AD; He C; Shi Y
    Cell Rep; 2017 Mar; 18(11):2622-2634. PubMed ID: 28297667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay of m
    Li F; Chen S; Yu J; Gao Z; Sun Z; Yi Y; Long T; Zhang C; Li Y; Pan Y; Qin C; Long W; Liu Q; Zhao W
    Clin Transl Med; 2021 Sep; 11(9):e553. PubMed ID: 34586728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m
    Chai RC; Chang YZ; Chang X; Pang B; An SY; Zhang KN; Chang YH; Jiang T; Wang YZ
    J Hematol Oncol; 2021 Jul; 14(1):109. PubMed ID: 34246306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N⁶-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling.
    Visvanathan A; Patil V; Abdulla S; Hoheisel JD; Somasundaram K
    Genes (Basel); 2019 Feb; 10(2):. PubMed ID: 30781903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.
    Chang YZ; Chai RC; Pang B; Chang X; An SY; Zhang KN; Jiang T; Wang YZ
    Cancer Lett; 2021 Jul; 511():36-46. PubMed ID: 33933553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m
    Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A
    Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m
    Chen J; Zhang YC; Huang C; Shen H; Sun B; Cheng X; Zhang YJ; Yang YG; Shu Q; Yang Y; Li X
    Genomics Proteomics Bioinformatics; 2019 Apr; 17(2):154-168. PubMed ID: 31154015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3-mediated m
    Wu Y; Chang N; Zhang Y; Zhang X; Xu L; Che Y; Qiao T; Wu B; Zhou Y; Jiang J; Xiong J; Zhang J; Zhang J
    J Exp Clin Cancer Res; 2021 Mar; 40(1):90. PubMed ID: 33676554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m
    Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
    Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL3 mediated m
    Zhou R; Gao Y; Lv D; Wang C; Wang D; Li Q
    Biochem Biophys Res Commun; 2019 Jul; 515(2):310-317. PubMed ID: 31153635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N
    Wang Q; Guo X; Li L; Gao Z; Su X; Ji M; Liu J
    Cell Death Dis; 2020 Oct; 11(10):911. PubMed ID: 33099572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N
    Jin H; Ying X; Que B; Wang X; Chao Y; Zhang H; Yuan Z; Qi D; Lin S; Min W; Yang M; Ji W
    EBioMedicine; 2019 Sep; 47():195-207. PubMed ID: 31409574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic m
    Yang F; Jin H; Que B; Chao Y; Zhang H; Ying X; Zhou Z; Yuan Z; Su J; Wu B; Zhang W; Qi D; Chen D; Min W; Lin S; Ji W
    Oncogene; 2019 Jun; 38(24):4755-4772. PubMed ID: 30796352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA m
    Lin Z; Niu Y; Wan A; Chen D; Liang H; Chen X; Sun L; Zhan S; Chen L; Cheng C; Zhang X; Bu X; He W; Wan G
    EMBO J; 2020 Jun; 39(12):e103181. PubMed ID: 32368828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KAP1 stabilizes MYCN mRNA and promotes neuroblastoma tumorigenicity by protecting the RNA m
    Yang Y; Zhang Y; Chen G; Sun B; Luo F; Gao Y; Feng H; Li Y
    J Exp Clin Cancer Res; 2024 May; 43(1):141. PubMed ID: 38745192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDGF signaling inhibits mitophagy in glioblastoma stem cells through N
    Lv D; Gimple RC; Zhong C; Wu Q; Yang K; Prager BC; Godugu B; Qiu Z; Zhao L; Zhang G; Dixit D; Lee D; Shen JZ; Li X; Xie Q; Wang X; Agnihotri S; Rich JN
    Dev Cell; 2022 Jun; 57(12):1466-1481.e6. PubMed ID: 35659339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.